Latest stories on SPRC
SciSparc Subsidiary NeuroThera Labs Closes Majority Acquisition of CliniQuantum
TipRanks67 · bullishm&a
SciSparc: Subsidiary NeuroThera Labs Completed Acquisition of CliniQuantum | SPRC Stock News
StockTitan67 · bullishm&a
SCISPARC LTD (SPRC) news roundup. 4 stories aggregated over the last 30 days. Average 30-day sentiment is 67/100. Recent insider activity (SEC Form 4, 90-day window): 0 purchases totalling $0 and 1 sales totalling $5K — net selling of $5K. No congressional trade disclosures in the last 90 days. Data shown on this page is delayed 4 hours. Real-time access — including the live wire, real-time alerts, the live S&P 500 heatmap, and the AI Top Trades long/short board — is available with a Top Tier Newswire Pro subscription.